The National Institutes of Health has opened enrollment for trials to evaluate potential treatments for long COVID. It's something that long COVID patients and advocates have been calling on for months after the NIH received more than a billion dollars from Congress to research the virus. The trials will test treatments that target the persistence of the Corona virus in the body and cognitive dysfunction related to long COVID. Doctor Steven Deeks with UC San Francisco says this could be a game changer.

The National Institutes of Health has opened enrollment for trials to evaluate potential treatments for long COVID. It's something that long COVID patients and advocates have been calling on for months after the NIH received more than a billion dollars from Congress to research the virus. The trials will test treatments that target the persistence of the Corona virus in the body and cognitive dysfunction related to long COVID. Doctor Steven Deeks with UC San Francisco says this could be a game changer.

There are smaller studies ongoing

There are smaller studies ongoing

um using PAX Ovid and other approaches and there are other studies that are ongoing looking at ways to manage people on COVID. But in terms of just really trying to hit a home run and to definitively answer the question whether or not we can cure this disease or this syndrome. This is the first study, although

um using PAX Ovid and other approaches and there are other studies that are ongoing looking at ways to manage people on COVID. But in terms of just really trying to hit a home run and to definitively answer the question whether or not we can cure this disease or this syndrome. This is the first study, although

the nah is hoping to get results in 6 to 12 months. Deek says with a trial, this large that could be difficult to actually achieve.

the nah is hoping to get results in 6 to 12 months. Deek says with a trial, this large that could be difficult to actually achieve.